🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
148,46 USD
Máx. histórico
156,92
14 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-5,39%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,24%
Cierre anterior
150,33
Rango de hoy
146,28 – 149,59
Volumen hoy
10.884.998
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 118,77 (puede no estar actualizado)
- Dividend yield
- 2,26% (puede no estar actualizado)
- Precio objetivo analistas
- 150,42 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 3 horas
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 15/06/2026 | 0,8500 USD |
| 16/03/2026 | 0,8500 USD |
| 15/12/2025 | 0,8500 USD |
| 15/09/2025 | 0,8100 USD |
| 16/06/2025 | 0,8100 USD |
| 17/03/2025 | 0,8100 USD |
| 16/12/2024 | 0,8100 USD |
| 16/09/2024 | 0,7700 USD |
| 17/06/2024 | 0,7700 USD |
| 14/03/2024 | 0,7700 USD |
| 14/12/2023 | 0,7700 USD |
| 14/09/2023 | 0,7300 USD |
| 14/06/2023 | 0,7300 USD |
| 14/03/2023 | 0,7300 USD |
| 14/12/2022 | 0,7300 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 18/05/1994 | 14,85 | 14,85 | 14,55 | 14,61 | -1,21% | 2,01% | 3.970.034 |
| 17/05/1994 | 14,55 | 14,91 | 14,49 | 14,79 | +1,22% | 2,87% | 5.090.555 |
| 16/05/1994 | 14,43 | 14,61 | 14,37 | 14,61 | +1,24% | 1,65% | 2.632.576 |
| 13/05/1994 | 14,49 | 14,49 | 14,25 | 14,43 | +0,00% | 1,65% | 2.629.851 |
| 12/05/1994 | 14,37 | 14,49 | 14,31 | 14,43 | +1,26% | 1,24% | 3.892.482 |
| 11/05/1994 | 14,61 | 14,67 | 14,25 | 14,25 | -2,45% | 2,86% | 3.690.637 |
| 10/05/1994 | 14,37 | 14,73 | 14,31 | 14,61 | +2,51% | 2,90% | 5.946.352 |
| 09/05/1994 | 14,25 | 14,55 | 14,19 | 14,25 | -0,83% | 2,51% | 4.680.997 |
| 06/05/1994 | 14,19 | 14,43 | 14,07 | 14,37 | +0,42% | 2,52% | 5.037.526 |
| 05/05/1994 | 14,49 | 14,55 | 14,31 | 14,31 | -0,41% | 1,65% | 2.477.262 |
| 04/05/1994 | 14,73 | 14,79 | 14,37 | 14,37 | -1,63% | 2,83% | 3.626.709 |
| 03/05/1994 | 15,03 | 15,09 | 14,55 | 14,61 | -1,61% | 3,57% | 6.688.546 |
| 02/05/1994 | 14,25 | 14,97 | 14,19 | 14,85 | +5,06% | 5,44% | 7.743.253 |
| 29/04/1994 | 14,25 | 14,43 | 14,07 | 14,13 | -1,66% | 2,51% | 4.701.747 |
| 28/04/1994 | 14,13 | 14,43 | 13,90 | 14,37 | -2,82% | 3,80% | 8.109.634 |
| 26/04/1994 | 14,73 | 14,79 | 14,37 | 14,79 | +0,41% | 2,83% | 5.599.254 |
| 25/04/1994 | 14,85 | 14,91 | 14,67 | 14,73 | -0,40% | 1,61% | 4.034.800 |
| 22/04/1994 | 14,79 | 14,91 | 14,61 | 14,79 | +0,41% | 2,02% | 5.911.139 |
| 21/04/1994 | 14,25 | 14,79 | 14,13 | 14,73 | +5,11% | 4,60% | 8.357.800 |
| 20/04/1994 | 13,60 | 14,01 | 13,60 | 14,01 | +3,52% | 3,07% | 9.152.603 |
| 19/04/1994 | 13,54 | 14,01 | 13,54 | 13,54 | -1,30% | 3,52% | 9.726.069 |
| 18/04/1994 | 13,54 | 13,90 | 13,42 | 13,72 | +1,32% | 3,52% | 6.960.397 |
| 15/04/1994 | 13,84 | 13,84 | 13,42 | 13,54 | -2,16% | 3,02% | 9.661.302 |
| 14/04/1994 | 13,84 | 14,01 | 13,78 | 13,84 | -1,28% | 1,72% | 6.033.336 |
| 13/04/1994 | 14,19 | 14,25 | 13,78 | 14,01 | -0,84% | 3,36% | 7.053.669 |
| 12/04/1994 | 14,25 | 14,37 | 14,07 | 14,13 | +0,00% | 2,09% | 5.322.582 |
| 11/04/1994 | 14,25 | 14,37 | 13,96 | 14,13 | -1,25% | 2,93% | 6.577.038 |
| 08/04/1994 | 14,13 | 14,43 | 14,13 | 14,31 | +0,84% | 2,11% | 4.906.526 |
| 07/04/1994 | 14,13 | 14,25 | 13,96 | 14,19 | +0,42% | 2,11% | 4.450.646 |
| 06/04/1994 | 14,37 | 14,49 | 14,13 | 14,13 | -1,66% | 2,49% | 4.541.403 |